Titlebook: Endocrine Neoplasms; Andrew Arnold (Chief, Associate Professor of Medic Book 1997 Springer Science+Business Media Dordrecht 1997 Tumor.can

整理

Developments in Cardiovascular Medicinee, and the oncology data that only 20–41% of adrenal metastases are detected by CT [1,3], it is likely that an increase in prevalence will occur if the spatial resolving capacity of abdominal imaging improves, if abdominal imaging occurs more frequently, and if routine abdominal imaging slice thickness is decreased.

山羊

D. Soga,R. Beer,J. Andrae,B. Bader the budding of isolated endocrine cells and islets from pancreatic duct cells, and severe infantile hypoglycemia [1]. Recent findings have elucidated the molecular cause for hyperinsulinemia in some families with this disorder, providing additional insight into the regulation of insulin secretion.

FECK

Henri J. Dumont,Stefan Schorreels, an MEN-I patient may present with clinical manifestations in all three organs simultaneously. This discussion will be limited to the surgical management of the parathyroid and pancreatic components of the syndrome.

潛伏期

Cougar

Persistent hyperinsulinemic hypoglycemia of infancy, the budding of isolated endocrine cells and islets from pancreatic duct cells, and severe infantile hypoglycemia [1]. Recent findings have elucidated the molecular cause for hyperinsulinemia in some families with this disorder, providing additional insight into the regulation of insulin secretion.

ventilate

amphibian

柏樹

Desert

Gastrin-producing tumors,e. In this chapter this general usage will be retained. Therefore, a tumor in which gastrin is detected, without associated hypergastrinemia or gastric hypersecretion, would not be included in the general use of this term. Tumors that produce gastrin but are not associated with hypergastrinemia clin

疏遠(yuǎn)天際

Multiple endocrine neoplasia type I Clinical genetics and diagnosis,cal MEN-I lesions almost invariably are benign but nevertheless may lead to considerable endocrine morbidity [6–10]. Early diagnosis and timely treatment instituted in order to avoid malignancy and endocrine morbidity comprise an increasing concern in MEN-I.